After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
CDNA belongs to the Healthcare sector of the NASDAQ while operating in the Diagnostics & Research industry. The current market capitalization of Caredx Inc is $1.24B. A total of 0.62 million shares were traded on the day, compared to an average of 786.06K shares.
In the most recent transaction, Novack Jeffrey Adam sold 1,917 shares of CDNA for 26.00 per share on Dec 04 ’24. After the transaction, the Secretary and General Counsel now owns 110,237 company shares. In a previous transaction on Dec 04 ’24, Jeffrey Adam Novack bought 1,917 shares at 24.96 per share.
Among the insiders who sold shares, Maag Peter disposed of 5,000 shares on Nov 26 ’24 at a per-share price of $25.00. This resulted in the Director holding 330,024 shares of CDNA after the transaction. In another insider transaction, Novack Jeffrey Adam sold 5,534 shares at $21.77 per share on Nov 18 ’24. Company shares held by the Secretary and General Counsel now total 113,377.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, CDNA has a high of $34.84 and a low of $7.42.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. CDNA’s latest balance sheet shows that the firm has $348.49M in Cash & Short Term Investments as of fiscal 2021. There were $21.35M in debt and $77.30M in liabilities at the time. Its Book Value Per Share was $5.15, while its Total Shareholder’s Equity was $465.88M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CDNA is Buy with a score of 4.25.
